December 15th, 2015

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Matthew Harrison

Recent news which mentions Matthew Harrison

< Previous 1 2 3 Next >
The Gilead, Galapagos Pipeline Opportunities That Are Turning Morgan Stanley Bullish
Tickers GILD GLPG
Tags Upgrades Benzinga Movers
From Benzinga
Sarepta Falls 50% To 10-Month Low After DMD Gene Therapy Study Misses Primary Endpoint
Tickers PFE SLDB SRPT
Tags Analyst Ratings SLDB Top Stories
From Benzinga
Moderna Analyst: COVID-19 Vaccine Value Largely Reflected In Stock
Tickers MRNA
Tags Matthew Harrison Analyst Ratings Market News
From Benzinga
Biogen Analysts Brace For Favorable Aducanumab Adcom Verdict
Tickers BIIB
Tags General News Upgrades
From Benzinga
COVID-19 Vaccines To Generate over $10B Annual Revenue, Analyst Say
Tickers AZN JNJ MRNA PFE
Tags Matthew Harrison Analyst Ratings The Financial Times
From Benzinga
2 Regeneron Analysts On COVID-19 Antibody Cocktail's Emergency Use Authorization Prospects
Tickers REGN
Tags Reiteration Matthew Harrison Christopher Raymond
From Benzinga
Gilead Analysts Dissect Immunomedics Deal: 'Pricier But Bold Move Into Oncology'
Tickers AZN GILD IMMU
Tags Jefferies Trading Ideas Analyst Color
From Benzinga
2 Moderna Analysts On Chances Of COVID-19 Vaccine Approval, Upcoming Catalysts
Tickers MRNA
Tags Benzinga MRNA Coronavirus
From Benzinga
Moderna Analysts Say COVID-19 Vaccine Contract Reflects Pricing Risk, Shows Ability To Scale
Tickers BNTX MRNA PFE
Tags Health Care Mani Foroohar Biotech
From Benzinga
Gilead Analysts Downplay Q2 Miss Amid Remdesivir's COVID-19 Opportunity
Tickers GILD
Tags Geoffrey Porges Analyst Color Biotech
From Benzinga
Morgan Stanley Double Upgrades Biogen, Says Alzheimer's Opportunity Ahead
Tickers BIIB
Tags Matthew Harrison Analyst Ratings Benzinga
From Benzinga
4 Ways Biogen's Tecfidera Generic Battle Could Play Out For The Stock
Tickers BIIB MYL
Tags News MYL Legal
From Benzinga
Moderna Analysts See Positives In Coronavirus Readout As Focus Shifts To Pivotal Phase 3 Study
Tickers BNTX MRNA PFE
Tags BNTX Market News Matthew Harrison
From Benzinga
Moderna Analyst Says Coronavirus Vaccine Candidate Has 65% Chance Of Success
Tickers MRNA
Tags General Coronavirus Benzinga
From Benzinga
These 6 Coronavirus Vaccine Candidates Are The Likeliest To Succeed, Says Morgan Stanley
Tickers AZN BNTX GSK JNJ
Tags Covid/19 Trading Ideas Health Care
From Benzinga
Gilead Analysts See Questionable Commercial Opportunity For Coronavirus Candidate Remdesivir
Tickers GILD UBS
Tags Navin Jacob Jim Birchenough Benzinga
From Benzinga
Gilead Analysts Tackle Early Results From Remdesivir Study In COVID-19, Morgan Stanley Says Stock Move Looks Overdone
Tickers GILD
Tags Wells Fargo RBC Capital Gregory Renza
From Benzinga
Analysts: Roche Partnership Derisks Sarepta Investor Concerns
Tickers RHHBY SRPT
Tags General Tazeen Ahmad Duchenne Muscular Dystrophy
From Benzinga
8 Biotech Stocks Morgan Stanley Recommends For 2020
Tickers ALEC AMGN FULC IBB
Tags IONS IBB Long Ideas
From Benzinga
Sell-Side Remains Optimistic On Sage Therapeutics Despite Depression Drug Disappointment
Tickers SAGE
Tags Morgan Stanley SAGE Price Target
From Benzinga
Gilead Falls On Uninspiring Q3 Print: 3 Analyst Takes
Tickers GILD
Tags Benzinga General Brian Skorney
From Benzinga
Biogen Analysts Debate About-Face On Aducanumab: 'Path To Market An Uphill Battle'
Tickers BIIB
Tags Alzheimer’s Mizuho Securities General
From Benzinga
Analysts Digest Biogen's Alzheimer's Disappointment: 'There Isn't Much To Be Excited About'
Tickers BIIB ESALY NVS UBS
Tags BIIB Short Ideas Analyst Color
From Benzinga
Janney, Morgan Stanley Say Sarepta's Gene Therapy Remains On Track
Tickers SRPT
Tags Janney General Yun Zhong
From Benzinga
Morgan Stanley: Moderna Has Significant Competitive Advantage
Tickers MRNA
Tags Biotech Price Target Morgan Stanley
From Benzinga
Sell-Side Slashes DBV Tech Price Targets After Withdrawal Of BLA For Peanut Allergy Immunotherapy
Tickers AIMT DBVT
Tags DBVT Benzinga News
From Benzinga
Woodlands-based midstream co. names new CFO, promotes other executives
Tags Marc Stratton Energy Matthew Harrison
From Business Journals
Morgan Stanley Buys Into Sarepta Amid Sell-Off, Sees $600M Recurring Opportunity In DMD Candidate
Tickers PFE SLDB SRPT
Tags Matthew Harrison Analyst Ratings SLDB
From Benzinga
Cytokinetics Downgraded On Data Delay
Tickers AMGN CYTK
Tags General CYTK AMGN
From Benzinga
Morgan Stanley: Newly Public Neon Therapeutics Has Outperformance Potential
Tickers BMY MRK NTGN
Tags Market News Analyst Ratings Initiation
From Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Medicine Hat News Twitter Twitter
Medicine Hat News Facebook Facebook
Medicine Hat News YouTube YouTube
Medicine Hat News Tumblr Tumblr

About Us

Contact the Medicine Hat News

3257 Dunmore Rd SE
Medicine Hat, AB T1B 3R2

[P] 403.527.1101
[F] 403.528.5696

Print Advertising: 403.528.5650
National Advertising: 403.528.5766
Online Advertising: 403.528.5698
Classifieds: 403.526.7653

© 1996-2015 The Medicine Hat News, A Division of Continental Newspapers Canada Ltd.